Related Experiment Videos
Drug Target Prioritization for Alzheimer's Disease Using Protein Interaction Network Analysis
Avijit Podder1, Mansi Pandit1, Latha Narayanan1
1Bioinformatics Infrastructure Facility, Sri Venkateswara College (University of Delhi) , Delhi, India .
Omics : a Journal of Integrative Biology
|October 23, 2018
Summary
This study identifies key genes linked to Alzheimer's disease (AD) using computational analysis of protein interactions. Presenilin 2 (PSEN2) emerged as a promising therapeutic target for AD drug discovery.
Area of Science:
- Neuroscience
- Computational Biology
- Genetics
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-beta protein accumulation and neurodegeneration.
- The complex genetic basis of AD necessitates a systems-level approach for effective therapeutic development.
Purpose of the Study:
- To computationally identify and prioritize genes associated with Alzheimer's disease.
- To investigate potential therapeutic targets for AD through network analysis and in silico modeling.
Main Methods:
- Integrative computational analysis of a protein-protein interaction network to identify AD-associated genes.
- Application of topological parameters to prioritize disease-susceptible proteins.
- In silico protein structure modeling and molecular dynamics simulations for target characterization.
Main Results:
- Identification of key AD-associated genes through network analysis.
- Presenilin 2 (PSEN2) was characterized as a significant target protein within the network.
- Computational methods provided insights into AD pathogenesis and potential therapeutic strategies.
Conclusions:
- The study highlights the utility of systems-level computational analysis in understanding AD genetics.
- Presenilin 2 (PSEN2) represents a promising target for future Alzheimer's disease drug discovery efforts.
- Findings offer a foundation for developing novel therapeutic interventions for Alzheimer's disease.